Starpharma Holdings Ltd. (OTCMKTS:SPHRY – Get Free Report) shot up 4.6% on Wednesday . The stock traded as high as $5.10 and last traded at $5.10. 3,490 shares were traded during mid-day trading, an increase of 257% from the average session volume of 978 shares. The stock had previously closed at $4.8750.
Starpharma Price Performance
The firm has a 50-day moving average price of $3.49 and a 200-day moving average price of $2.78.
About Starpharma
Starpharma is a clinical-stage biopharmaceutical company specializing in the development of dendrimer-based products across infectious disease, oncology and ophthalmology. Its proprietary dendrimer platform, DEP™ (Dendrimer Enhanced Products), enables precise molecular engineering to enhance drug delivery, targeting and safety profiles. The company’s lead product, VivaGel®, is a topical microbicide that has been approved in multiple markets for the treatment and prevention of bacterial vaginosis and is in clinical development for antiviral applications.
In addition to VivaGel, Starpharma is advancing pipeline candidates that leverage DEP technology to improve the performance of established and novel therapeutic agents.
Read More
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
